Hospital or health organisation · founded 1934
Jewish General Hospital
Montreal, Canada · jgh.ca
Part of Gouvernement du Québec
- Citations, last 5 years
- 42.1k
- Works, last 5 years
- 4 334
- h-index
- 571
- Scientists listed
- 0
- Grants since 2016
- 34
Grants received
2026
Tissue Engineering of Intervertebral Disc
2026
Molecular Mechanisms of Neurodegeneration in Alzheimer disease.
2026
Deciphering the role of post-transcriptional gene expression networks in regulation of gene expression in normal and cancer cells
2026
High-resolution characterization of patient-derived transcriptomes in heavily-mutated skin cancers
2026
Oncogenic Fusion Protein unit at McGill University
2026–2029 · research · Challenge Grants
Improving survival for people with aggressive lymphomas
Nathalie Johnson · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2026–2031 · research · Emerging Scholar Research Grants
Better tests and treatments to prevent bladder cancer recurrence
Côme Tholomier · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2026–2031 · research · Emerging Scholar Research Grants
Stopping cancer cells from spreading through the body
Loïc Binan · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2024–2026 · award
Maternal and Neonatal Outcomes of Cesarean Deliveries in Women with Muscular Dystrophy
Haim Abenhaim · Jewish General Hospital · funded by Muscular Dystrophy Canada
2024–2027 · fellowship · Research Training Awards
New treatment strategies for people with BRAF mutations in their tumours
Islam Elkholi · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2024–2027 · fellowship · Research Training Awards
Understanding why skin cancer spreads to other parts of the body
Maryam Ahmadi · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2023–2025 · research · Challenge Grants
Giving CAR T-cells earlier to people with relapsed lymphoma
Nathalie Johnson · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2023–2024 · fellowship · Research Training Awards
Exploring the mutational landscape of RAS in cancers with Class 2/3 BRAF mutations
Chantel Mukonoweshuro · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2022 · grant · Team grants — Brain Canada-Women's Brain Health Initiative Expansion Grants: Considering Sex and Gender
CanStim Platform: Sex and Gender-Based Analysis Expansion
Alexander Thiel · Jewish General Hospital · funded by Fondation Brain Canada
2022 · grant · New Frontiers in Research Fund - Special Calls
Culturally adapting post-pandemic mental health services for Canadian Black youth with early psychosis and their families
Jarvis, G. Eric · Jewish General Hospital · funded by Social Sciences and Humanities Research Council of Canada
2022 · grant · New Frontiers in Research Fund - Special Calls
Culturally adapting post-pandemic mental health services for Canadian Black youth with early psychosis and their families
Jarvis, G. Eric · Jewish General Hospital · funded by Social Sciences and Humanities Research Council of Canada
2022 · research · Operating Grants
Le rôle de la flavoprotéine déshydrogénase par transfert d'électrons (ETFDH) dans le cancer
Ivan Topisirovic · Jewish General Hospital · funded by Cancer Research Society
2022 · research · Operating Grants (co-funded: Instituts de recherche en santé du Canada - Institut du cancer)
Décryptage du rôle de l'ubiquitine ligase E3 HERC1 dans la réponse de la leucémie aiguë myéloïde à la chimiothérapie
Francois Mercier · Jewish General Hospital · funded by Cancer Research Society
2022 · research · Operating Grants (co-funded: Fondation cancer du sein du Québec)
Cellules souches mésenchymateuses modifiées génétiquement pour le traitement du cancer du sein
Nicoletta Eliopoulos · Jewish General Hospital · funded by Cancer Research Society
2022 · research · Operating Grants
Explorer des inhibiteurs de MNK1/2 pour surmonter la résistance aux inhibiteurs de CDK4/6 dans le cancer du sein
Wilson Miller · Jewish General Hospital · funded by Cancer Research Society
2022 · career development · Career Development Award
Evaluating the dynamic molecular landscape of MAPK inhibitor resistance in patients with non-V600 BRAF mutant cancers
April Rose · Jewish General Hospital · funded by Conquer Cancer Foundation
2021 · grant · New Frontiers in Research Fund - Special Call
Comparison of Depression Research Diagnoses and Symptom Scores Obtained via Conventional In-person and Alternative Methodologies
Thombs, Brett · Jewish General Hospital · funded by Social Sciences and Humanities Research Council of Canada
2021–2023 · award
Promoting Muscle Repair by Pharmacological Inhibition of eIF2a Dephosphorylation
Colin Crist · Jewish General Hospital · funded by Muscular Dystrophy Canada
2021–2024 · research · Challenge Grants
Defining the critical genomic dependencies of non-V600 BRAF mutant tumors to optimize therapeutic strategies
April Rose · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2021–2024 · research · Challenge Grants
Targeting lipid reprogramming in chemoresistant triple negative breast cancer
Mark Basik · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2021–2024 · research · Challenge Grants
Exploiting STAT1-induced oxidative stress to potentiate the tumoricidal response of metabolic therapies
Josie Ursini-Siegel · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2021–2026 · research · Emerging Scholar Awards
Examining the MNK1/2 eIF4E axis in cancer associated fibroblasts as a driver of oncogenic progression
Sonia Del Rincon · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2020–2022 · research · Innovation Grants
2B or not 2B: that is the question about KRAS function.
Antonis Koromilas · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2020–2023 · research · innovation to impact grants
Capitalizing on an oxidative stress response to sensitize poor outcome cancers to PARP inhibitors.
Josie Ursini Siegel · Jewish General Hospital · funded by Canadian Cancer Society Research Institute
2019 · grant · New Frontiers in Research Fund - Exploration
Artificial Intelligence Assisted Emergency Department Flow
Grant, Lars · Jewish General Hospital · funded by Social Sciences and Humanities Research Council of Canada
2017–2022 · grant
The role of epitranscriptome and translational dysregulation in cancer
Jewish General Hospital · funded by International Development Research Centre
2016 · career development · Young Investigator Award
The Use of Metformin and the Incidence of Lymphoid Malignancies in Patients with Type 2 Diabetes Mellitus
Adi Klil-Drori · Jewish General Hospital · funded by Conquer Cancer Foundation
2005–2030 · grant · Chercheurs-boursiers de mérite - subvention
Soins personnalisés pour les patients âgés utilisant des biomarqueurs d'imagerie alimentés par intelligence artificielle
Jonathan Afilalo · Jewish General Hospital · funded by Fonds de recherche du Québec
2005–2030 · salary-award · Chercheurs-boursiers et chercheuses-boursières de mérite
Soins personnalisés pour les patients âgés utilisant des biomarqueurs d'imagerie alimentés par intelligence artificielle
Jonathan Afilalo · Jewish General Hospital · funded by Fonds de recherche du Québec